True partnership. True integration.
We’re deeply connected where medicines play a role through true integration to unlock better, more affordable care together. That’s why we focus on creating partnerships across the continuum to enable the right care for each person, with the right medicine, at the right place.
Blue + Prime
Better together
We’re committed to unlocking the potential of integration. That means alignment, transparency, pass-through and commitment in all we do. Together with our Blue Plan partners, we’re helping make health care easier for patients, providers, and plan sponsors.
Alignment
Rather than pushing clients to owned assets that boost our bottom line, we offer flexible solutions and freedom of choice.
Transparency
With Blue Plans as both owners and clients, our model helps ensure an unbiased approach without conflict or compromise. Your goals are our goals.
Pass-through
Shared success is our standard, with pass-through of savings. We’re motivated by better outcomes, not bigger profits.
Compliance
Trust built on actions, not just words
Every action we take is anchored in our core values of integrity, honesty and respect. We’re serious about defending members’ security and privacy. We protect our clients by complying with all applicable laws and regulations, in addition to our own Code of Conduct. Ask around — our reputation speaks for itself. In fact, we had no corrective action plans following Centers for Medicare and Medicaid Systems (CMS) program audits in 2018–2020.
Member experience
Member-centric to the core
Our reputation for excellent service is reflected in our industry-leading results: More than 80% of member calls are answered in 30 seconds or less, and 95% of issues are resolved right away. But it doesn’t end there. We make the member’s experience central in everything we do – from product development to formulary management, and beyond.
Culture
Purposeful people
Our culture inspires purpose and service to others, which enables our people to thrive. Evidence of employees’ passion can be seen in their award-winning work. And our award-winning workplace is further evidence that working with purpose is good for everyone.
People. Purpose. Possibilities.
Culture revolves around people, purpose and possibilities. Employees have lived our culture for more than 20 years by serving members and clients, making health care work better and looking beyond today and defining what’s next.
Flexible workplaces
When it comes to new ways of working, we’re on the leading edge. We rapidly transitioned to remote work at the start of the pandemic in 2020. When offices reopen, our hybrid approach will meet employees’ needs for flexibility and connection.
Explore opportunities at Prime
In today’s complex health care system, helping people get the medicine they need demands a variety of skills. If working with purpose ignites your passion, then Prime could be the perfect place for you to grow your career.
Community
Driven to serve
Our passion to help extends beyond managing integrated pharmacy benefits. On any given day, Prime people can be found serving others in the communities where we live and work.
Community giving
Prime’s community giving program, PrimeCares, brings employees together to donate, volunteer and participate in community events. Employees raised more than $400,000 for charity partners in 2020.
Prime Together Foundation
Born out of employees’ passion to address social injustice, this 501(C)(3) entity helps address inequality and injustice in all its manifestations, particularly racism, poverty, health and hunger.
Diversity & inclusion
When a person feels safe to be who they are, they’re able to do their best work. Prime’s diversity and inclusion council and resource groups help employees celebrate differences, find like-minded people and feel connected.
Recognition
Award-winning people. Award-winning work.
Delivering unmatched care, groundbreaking research and industry-leading programs and services to health plans, employers and members.
Award-winning research
Drug pipeline updates
November 30, 2021
Biosimilar strategy for bevacizumab using MedDrive™
Avastin® (bevacizumab) from Genentech was first approved in 2004. It has received FDA…
Drug pipeline updates
November 29, 2021
Drug Pipeline Update: November 2021
This monthly pipeline wrap up provides a review of newly approved drugs, recent…
Drug pipeline updates
November 23, 2021
MedDrive™ derives biosimilar savings from oncology monoclonal antibodies
MedDrive has identified cost-saving biosimilar strategies for three oncology biosimilars: rituximab (Rituxan®—reference drug)…